![](/img/cover-not-exists.png)
128OPhase I study of S-trans, trans-farnesylthiosalicylic acid (salirasib), a novel oral RAS inhibitor in Japanese patients with advanced solid tumors
Shimizu, T., Okano, N., Kurata, T., Naruge, D., Fujisaka, Y., Kitamura, H., Nagashima, F., Nakagawa, K., Furuse, J.Volume:
26
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdv521.04
Date:
December, 2015
File:
PDF, 32 KB
english, 2015